Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8439444 | European Journal of Cancer | 2018 | 9 Pages |
Abstract
Adequate stratification of positive SN patients was possible based on ulceration and SN tumour burden category. The identification of low-, intermediate- and high-risk patients could guide adjuvant therapy in clinical practice. Omitting CLND seems to have little consequences.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Daniëlle Verver, David van Klaveren, Alexander C.J. van Akkooi, Piotr Rutkowski, Barry W.E.M. Powell, Caroline Robert, Alessandro Testori, Barbara L. van Leeuwen, Astrid A.M. van der Veldt, Ulrich Keilholz, Alexander M.M. Eggermont, Cornelis Verhoef,